Upcoming NIAMS R21 funding for ancillary studies using ongoing clinical study data, samples, and cohorts (no clinical trials)
NIAMS plans to issue an R21 funding opportunity for ancillary studies that leverage ongoing clinical cohorts, infrastructure, data, and biospecimens. Parent studies may be outside NIAMS, but the ancillary project must align with the NIAMS mission; clinical trials are not allowed. This is a pre-announcement and applications are not yet being accepted.
Source
Award
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
Get the full picture on this opportunity
Create a free Scout account to unlock everything you need to decide fast and win the grant.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Deep agency & funder detail
Program context, sub-agency structure, and a full eligibility breakdown.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Similar opportunities
Discover related funding matched to your work.
Already have an account? Sign In
Trusted by 500+ Happy Customers